← Leaderboards
Tomas Kirchhoff
Sloan-Kettering Inst Can Research
$7,026,619
Attributed
$8,525,599
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,525,599 · 6
By mechanism
R01$5,522,603 · 2
P50$1,989,140 · 1
R21$1,013,856 · 3
Top collaborators
- Jeffrey S Weber5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Ronglai Shen$3,190,387
- Iris Lansdorp-Vogelaar$3,610,882
- Mark Thomas Burgess$731,872
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMutationPathway InteractionsInheritedTumorVariantCohortMolecularBaseGeneticMelanomaAffectGenomicsTranscriptome SequencingMalignant NeoplasmsResponseGenome SequencingEpigenetic ProcessRare VariantRegulationInnovationSamplingT-LymphocyteImmune
Grant awards (23)
Project 2$313,265
P50 · FY2025 · CA · contact PI
Project 2$243,390
P50 · FY2024 · CA · contact PI
Project 2$294,092
P50 · FY2023 · CA · contact PI
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade$510,554
R01 · FY2022 · CA · contact PI
Project 2$283,281
P50 · FY2022 · CA · contact PI
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade$627,894
R01 · FY2021 · CA · contact PI
Project 2$283,399
P50 · FY2021 · CA · contact PI
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade$639,149
R01 · FY2020 · CA · contact PI
Project 2$289,614
P50 · FY2020 · CA · contact PI
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade$599,504
R01 · FY2019 · CA · contact PI
The identification of genetic determinants of melanoma recurrence$442,152
R01 · FY2019 · CA · contact PI
Project 2$282,099
P50 · FY2019 · CA · contact PI
The identification of genetic determinants of melanoma recurrence$629,257
R01 · FY2018 · CA · contact PI
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade$620,860
R01 · FY2018 · CA · contact PI
The identification of genetic determinants of melanoma recurrence$484,247
R01 · FY2017 · CA · contact PI
The identification of genetic determinants of melanoma recurrence$490,060
R01 · FY2016 · CA · contact PI
The identification of genetic determinants of melanoma recurrence$478,926
R01 · FY2015 · CA · contact PI
The genetic markers of ipilimumab response in patients with metastatic melanoma$184,331
R21 · FY2015 · CA · contact PI
The genetic markers of ipilimumab response in patients with metastatic melanoma$221,198
R21 · FY2014 · CA · contact PI
The germline variation in immune and epigenetic pathways and melanoma prognosis$169,391
R21 · FY2013 · CA · contact PI
Genetic Variation Affecting Epigenome and Breast Cancer Susceptibility$164,598
R21 · FY2011 · CA · contact PI
Genetic Variation Affecting Epigenome and Breast Cancer Susceptibility$25,213
R21 · FY2011 · CA · contact PI
Genetic Variation Affecting Epigenome and Breast Cancer Susceptibility$249,125
R21 · FY2010 · CA · contact PI